Clinical trial

HRT Versus Etidronate for Osteoporosis and Fractures in Asthmatics Receiving…

NCT00376662 · British Thoracic Society, Other · Completed

Key facts

NCT number NCT00376662
Title HRT Versus Etidronate for Osteoporosis and Fractures in Asthmatics Receiving Glucocorticoids.
Official title HRT and/or Etidronate in the Prevention and Treatment of Osteoporosis and Fractures in Post-Menopausal Patients With Asthma Receiving Long-Term Oral and/or Inhaled Glucocorticoids:a Randomised Factorial Trial
Lead sponsor British Thoracic Society, Other
Status Completed
Phase Phase 4
Study type Interventional
Conditions Osteoporosis
Intervention type Drug
Interventions Hormone Replacement Therapy and Etidronate
Enrollment 750
Start date Aug 1, 1992
Completion Oct 1, 2000
First posted Sep 15, 2006
Last update posted Sep 15, 2006
Countries United Kingdom

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies